IDL Biotech AB

Karlsbodavägen 39, 5th
168 67 Bromma
Sweden
P.O. Box 1 11 51
161 11 Bromma

Phone: +46 8 7996750
Fax: +46 8 7999320
http://www.idl.se
idlbiotech@idl.se

Manufacturers

Company Figures
Number of employees 1-19
Area of business Diagnostics

Company Profile

IDL offers tumour markers for monitoring of disease activity
IDL Biotech develops, manufactures and markets tumor markers for management of various forms of cancer. Our tests, TPS, TPAcyk, MonoTotal and UBC, are cytokeratin tumor markers aimed for patients with epithelial cancers (e.g. breast, prostate, ovarian, lung and urinary bladder), primarily for prognosis, monitoring and follow-up after concluded therapy. These tumor markers indicate ongoing tumor cell activity, giving a both rapid and distinct response of applied therapy effect and/or relapse of the disease.
In addition, TUBEX TF, a highly sensitive, rapid and semi-quantitative test for diagnosis of typhoid fever now takes part of IDL’s product panel.

idiag AG
IDEX Health & Science Group
Ideal Medical Industries Co., Ltd.
ID Information und Dokumentation im Gesundheitswesen GmbH & Co. KGaA
ICOS IMPIANTI GROUP S.p.A.

IDS Ltd.
ifap Service-Institut für Ärzte und Apotheker GmbH
IfM GmbH, Ingenieurbüro für Medizintechnik
Iftest medical electronics AG
IG Media Co., Ltd.